| 17alpha-ethynylestradiol | increases expression | ISO | RGD:736949 | 6480464 | Ethinyl Estradiol results in increased expression of PPP1R1B mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | ISO | RGD:621859 | 6480464 | Estradiol results in increased expression of PPP1R1B mRNA | CTD | PMID:20068009 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of PPP1R1B mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621859 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPP1R1B mRNA | CTD | PMID:18465118 |
| 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine | increases phosphorylation | ISO | RGD:736949 | 6480464 | 4-iodo-2,5-dimethoxyphenylisopropylamine results in increased phosphorylation of PPP1R1B protein | CTD | PMID:11880652 |
| 5-fluorouracil | increases response to substance | EXP | | 6480464 | PPP1R1B protein results in increased susceptibility to Fluorouracil | CTD | PMID:17470401 |
| all-trans-retinoic acid | increases expression | ISO | RGD:621859 | 6480464 | Tretinoin results in increased expression of PPP1R1B mRNA | CTD | PMID:16026464 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736949 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of PPP1R1B mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:736949 | 6480464 | Benzo(a)pyrene results in decreased expression of PPP1R1B mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:621859 | 6480464 | Benzo(a)pyrene results in decreased expression of PPP1R1B mRNA | CTD | PMID:21839799 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PPP1R1B mRNA | CTD | PMID:23019147 |
| camptothecin | decreases response to substance | EXP | | 6480464 | PPP1R1B protein results in decreased susceptibility to Camptothecin; more ... | CTD | PMID:16061638 |
| cisplatin | increases response to substance | EXP | | 6480464 | PPP1R1B protein results in increased susceptibility to Cisplatin | CTD | PMID:17470401 |
| clozapine | multiple interactions | ISO | RGD:736949 | 6480464 | Clozapine inhibits the reaction [Serotonin results in decreased phosphorylation of PPP1R1B protein]; more ... | CTD | PMID:11880652 |
| clozapine | increases phosphorylation | ISO | RGD:736949 | 6480464 | Clozapine results in increased phosphorylation of PPP1R1B protein | CTD | PMID:12871586 |
| cocaine | multiple interactions | ISO | RGD:736949 | 6480464 | CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of PPP1R1B protein] | CTD | PMID:15665076 |
| cocaine | affects phosphorylation | ISO | RGD:621859 | 6480464 | Cocaine affects the phosphorylation of PPP1R1B protein | CTD | PMID:15287884 PMID:17680995 |
| cocaine | increases phosphorylation | ISO | RGD:736949 | 6480464 | Cocaine results in increased phosphorylation of PPP1R1B protein | CTD | PMID:15665076 PMID:17596442 |
| cocaine | multiple interactions | ISO | RGD:621859 | 6480464 | roscovitine affects the reaction [Cocaine affects the phosphorylation of PPP1R1B protein]; more ... | CTD | PMID:11268215 |
| cocaine | affects phosphorylation | ISO | RGD:621859 | 6480464 | Cocaine affects the phosphorylation of PPP1R1B protein | CTD | PMID:17680995 PMID:15287884 |
| cocaine | increases response to substance | ISO | RGD:736949 | 6480464 | PPP1R1B mutant form results in increased susceptibility to Cocaine | CTD | PMID:11268215 |
| cocaine | multiple interactions | ISO | RGD:621859 | 6480464 | 6-methyl-2-(phenylethynyl)pyridine affects the reaction [Cocaine affects the phosphorylation of PPP1R1B protein] | CTD | PMID:17680995 |
| cocaine | multiple interactions | ISO | RGD:736949 | 6480464 | PPP1R1B gene mutant form inhibits the reaction [Cocaine results in increased expression of FOSB protein] | CTD | PMID:10103106 |
| cocaine | increases response to substance | ISO | RGD:736949 | 6480464 | PPP1R1B gene mutant form results in increased susceptibility to Cocaine | CTD | PMID:10103106 |
| cocaine | affects response to substance | ISO | RGD:736949 | 6480464 | PPP1R1B affects the susceptibility to Cocaine | CTD | PMID:20682746 |
| cocaine | multiple interactions | ISO | RGD:736949 | 6480464 | N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine inhibits the reaction [Cocaine results in increased expression of PPP1R1B protein] | CTD | PMID:16710312 |
| cocaine | increases phosphorylation | ISO | RGD:736949 | 6480464 | Cocaine results in increased phosphorylation of PPP1R1B protein | CTD | PMID:17596442 PMID:15665076 |
| cocaine | increases expression | ISO | RGD:736949 | 6480464 | Cocaine results in increased expression of PPP1R1B protein | CTD | PMID:16710312 |
| cocaine | multiple interactions | ISO | RGD:736949 | 6480464 | Cocaine promotes the reaction [PPP1R1B protein results in increased abundance of Adrenocorticotropic Hormone]; more ... | CTD | PMID:10516482 |
| cocaine | multiple interactions | ISO | RGD:736949 | 6480464 | CNR1 gene mutant form inhibits the reaction [Cocaine results in increased phosphorylation of PPP1R1B protein] | CTD | PMID:17596442 |
| corticosterone | multiple interactions | ISO | RGD:736949 | 6480464 | Cocaine promotes the reaction [PPP1R1B protein results in increased abundance of Corticosterone] | CTD | PMID:10516482 |
| corticotropin | multiple interactions | ISO | RGD:736949 | 6480464 | Cocaine promotes the reaction [PPP1R1B protein results in increased abundance of Adrenocorticotropic Hormone] | CTD | PMID:10516482 |
| doxorubicin | decreases export | EXP | | 6480464 | PPP1R1B protein results in decreased export of Doxorubicin | CTD | PMID:17470401 |
| doxorubicin | increases response to substance | EXP | | 6480464 | PPP1R1B protein results in increased susceptibility to Doxorubicin | CTD | PMID:17470401 |
| ethanol | increases expression | ISO | RGD:736949 | 6480464 | Ethanol results in increased expression of PPP1R1B mRNA | CTD | PMID:19167417 |
| fluoxetine | affects phosphorylation | ISO | RGD:736949 | 6480464 | Fluoxetine affects the phosphorylation of PPP1R1B protein | CTD | PMID:11880651 |
| fluoxetine | increases response to substance | ISO | RGD:736949 | 6480464 | PPP1R1B protein results in increased susceptibility to Fluoxetine | CTD | PMID:11880651 |
| fluoxetine | multiple interactions | ISO | RGD:736949 | 6480464 | PPP1R1B protein promotes the reaction [Fluoxetine affects the phosphorylation of GRIA1 protein] | CTD | PMID:11880651 |
| fluoxetine | increases expression | ISO | RGD:736949 | 6480464 | Fluoxetine results in increased expression of PPP1R1B mRNA; more ... | CTD | PMID:11880651 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of PPP1R1B mRNA | CTD | PMID:23019147 |
| haloperidol | increases phosphorylation | ISO | RGD:736949 | 6480464 | Haloperidol results in increased phosphorylation of PPP1R1B protein | CTD | PMID:12871586 |
| indole-3-methanol | affects expression | ISO | RGD:621859 | 6480464 | indole-3-carbinol affects the expression of PPP1R1B mRNA | CTD | PMID:21396975 |
| iron atom | increases expression | ISO | RGD:621859 | 6480464 | Iron deficiency results in increased expression of PPP1R1B mRNA | CTD | PMID:16629162 |
| ketamine | increases expression | ISO | RGD:621859 | 6480464 | Ketamine results in increased expression of PPP1R1B mRNA | CTD | PMID:20080153 |
| ketanserin | multiple interactions | ISO | RGD:736949 | 6480464 | Ketanserin inhibits the reaction [Serotonin results in increased phosphorylation of PPP1R1B protein] | CTD | PMID:11880652 |
| LY294002 | multiple interactions | ISO | RGD:736949 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [BDNF protein results in increased expression of PPP1R1B mRNA]; more ... | CTD | PMID:17209049 |
| manganese atom | increases phosphorylation | ISO | RGD:621859 | 6480464 | Manganese results in increased phosphorylation of PPP1R1B protein | CTD | PMID:22427945 |
| manganese(0) | increases phosphorylation | ISO | RGD:621859 | 6480464 | Manganese results in increased phosphorylation of PPP1R1B protein | CTD | PMID:22427945 |
| methamphetamine | multiple interactions | ISO | RGD:736949 | 6480464 | naloxonazine inhibits the reaction [Methamphetamine results in increased phosphorylation of PPP1R1B protein] | CTD | PMID:22564758 |
| methamphetamine | increases phosphorylation | ISO | RGD:736949 | 6480464 | Methamphetamine results in increased phosphorylation of PPP1R1B protein | CTD | PMID:22564758 |
| methotrexate | affects expression | ISO | RGD:736949 | 6480464 | Methotrexate affects the expression of PPP1R1B mRNA | CTD | PMID:18502557 |
| morphine | affects expression | ISO | RGD:621859 | 6480464 | Morphine affects the expression of PPP1R1B protein modified form | CTD | PMID:15287884 |
| morphine | multiple interactions | EXP | | 6480464 | OPRD1 mutant form inhibits the reaction [Morphine results in increased phosphorylation of PPP1R1B protein]; more ... | CTD | PMID:21600884 |
| morphine | multiple interactions | ISO | RGD:621859 | 6480464 | ARL6IP5 mutant form inhibits the reaction [Morphine results in increased phosphorylation of PPP1R1B protein] | CTD | PMID:21600884 |
| morphine | increases phosphorylation | ISO | RGD:621859 | 6480464 | Morphine results in increased phosphorylation of PPP1R1B protein | CTD | PMID:21600884 |
| O-methylserotonin | decreases phosphorylation | ISO | RGD:736949 | 6480464 | 5-Methoxytryptamine results in decreased phosphorylation of PPP1R1B protein | CTD | PMID:11880652 |
| O-methylserotonin | increases phosphorylation | ISO | RGD:736949 | 6480464 | 5-Methoxytryptamine results in increased phosphorylation of PPP1R1B protein | CTD | PMID:11880652 |
| paracetamol | affects expression | ISO | RGD:736949 | 6480464 | Acetaminophen affects the expression of PPP1R1B mRNA | CTD | PMID:17562736 |
| pirinixic acid | decreases expression | ISO | RGD:736949 | 6480464 | pirinixic acid results in decreased expression of PPP1R1B mRNA | CTD | PMID:17426115 |
| progesterone | decreases expression | ISO | RGD:736949 | 6480464 | Progesterone results in decreased expression of PPP1R1B mRNA | CTD | PMID:16966611 |
| serotonin | multiple interactions | ISO | RGD:736949 | 6480464 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Serotonin results in increased phosphorylation of PPP1R1B protein]; more ... | CTD | PMID:11880652 |
| serotonin | increases phosphorylation | ISO | RGD:736949 | 6480464 | Serotonin results in increased phosphorylation of PPP1R1B protein | CTD | PMID:11880652 |
| serotonin | decreases phosphorylation | ISO | RGD:736949 | 6480464 | Serotonin results in decreased phosphorylation of PPP1R1B protein | CTD | PMID:11880652 |
| sirolimus | multiple interactions | ISO | RGD:736949 | 6480464 | Sirolimus inhibits the reaction [BDNF protein results in increased expression of PPP1R1B mRNA]; more ... | CTD | PMID:17209049 |
| titanium dioxide | decreases expression | ISO | RGD:736949 | 6480464 | titanium dioxide results in decreased expression of PPP1R1B mRNA | CTD | PMID:19464567 |
| valproic acid | affects expression | ISO | RGD:736949 | 6480464 | Valproic Acid affects the expression of PPP1R1B mRNA | CTD | PMID:17292431 |
| vancomycin | increases expression | ISO | RGD:736949 | 6480464 | Vancomycin results in increased expression of PPP1R1B mRNA | CTD | PMID:18930951 |
| vincristine | increases response to substance | EXP | | 6480464 | PPP1R1B protein results in increased susceptibility to Vincristine | CTD | PMID:17470401 |
| wortmannin | multiple interactions | ISO | RGD:736949 | 6480464 | wortmannin inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein] | CTD | PMID:17209049 |